Last reviewed · How we verify
NCT05348629
Efficacy and Safety of Covid-19 Vaccine in Cardiac Patients
trial in COVID-19 Vaccine in 50 participants. Status unknown.
1 June 2022
Quick facts
| Lead sponsor | Mina sobhi said fam |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 1 June 2022 |
| Primary completion | 1 June 2022 |
| Estimated completion | 1 September 2023 |
| Sites | 2 locations across Egypt |
Conditions studied
- COVID-19 Vaccine — all drugs for COVID-19 Vaccine →
Sponsor
Mina sobhi said fam
Who can join
Adults 18 to 80, any sex, with COVID-19 Vaccine. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Efficacy and safety of covid-19 vaccine in Cardiac patients
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05348629
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COVID-19 Vaccine
Currently open trials in the same condition.
- NCT06950177 — Pancoronavirus Vaccine Study in Healthy Adults · Phase 1 · active not recruiting
- NCT06821100 — Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COV · Phase 1 · recruiting
- NCT05822219 — Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases · NA · active not recruiting
- NCT05869968 — SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI · active not recruiting
Other Mina sobhi said fam trials
Trials by the same sponsor.
- NCT06244056 — Stellate Ganglion Block as Novel Treatment for Heart Failure Patients · Phase 2, PHASE3 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05348629 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mina sobhi said fam
- Last refreshed: 27 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05348629.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing